加强和规范综合医疗机构结核病预防性治疗工作  

Strengthening and standardizing the preventive treatment for tuberculosis in comprehensive medical facilities

作　　者：高磊 曹彬 Gao Lei;Cao Bin(National Institute of Pathogen Biology,Tuberculosis Research Center,Chinese Academy of Medical Sciences,Beijing 102629,China;National Respiratory Medicine Center,National Key Laboratory of Respiratory Diseases and Comorbidity,National Respiratory Disease Clinical Research Center,Institute of Respiratory Diseases,Chinese Academy of Medical Sciences,Respiratory Center,Department of Respiratory and Critical Care Medicine,China-Japan Friendship Hospital,Beijing 100029,China)

机构地区：[1]中国医学科学院病原生物学研究所,中国医学科学院结核病研究中心,北京102629 [2]国家呼吸医学中心,呼吸和共病全国重点实验室,国家呼吸疾病临床研究中心,中国医学科学院呼吸病学研究院,中日友好医院呼吸中心呼吸与危重症医学科,北京100029

出　　处：《中华结核和呼吸杂志》2024年第10期906-908,共3页Chinese Journal of Tuberculosis and Respiratory Diseases

基　　金：中国医学科学院医学与健康科技创新工程(2021-I2M-1-037)。

摘　　要：针对结核病发病高危人群开展预防性治疗是结核病防控工作的重要内容, 综合医疗机构承担着重要职能。本刊本期发表了《综合医疗机构结核病发病高危人群的预防性治疗专家共识》。该共识根据综合医疗机构涉及结核病发病高危人群的情况界定了预防性治疗目标人群, 针对不同人群推荐了预防性治疗时机和方案, 并对预防性治疗的管理提出了建议, 将有利于指导综合医疗机构不同学科更加规范的开展结核病预防性治疗工作。本文就该共识的形成背景和临床意义进行补充和探讨。Preventive treatment of high-risk groups for tuberculosis is an important part of tuberculosis prevention and control strategies,and comprehensive medical facilities have an important role to play.This issue of the journal published the“Expert consensus on tuberculosis preventive treatment for individuals at high risk of developing active diseases from latent tuberculosis infection in comprehensive medical facilities”.The consensus defined the target population for tuberculosis preventive treatment,recommended the timing of treatment initiation and optional treatment regimens for different groups,and put forward suggestions for the management of preventive treatment.It helped to guide the comprehensive medical facilities to provide more standardized tuberculosis preventive treatment.This article discussed the background and clinical significance of the consensus.

关 键 词：预防性治疗 综合医疗机构 目标人群 结核病 高危人群 专家共识 临床意义 

分 类 号：R52[医药卫生—内科学]